The workplace project – putting learning into practice

Taking practical education to a fundamental level, every two-module MasterClass includes an intermodule project as a mandatory part of the course. An opportunity to test new knowledge and skills and to improve local services, delegates are offered mentorship and encouraged to support their peers as they continue to develop their specialism in a way that directly impacts their patient's outcomes.

Attendees have free reign over this project. It might be service delivery, patient management or drug treatments, and it could take the form of a service description, an audit, or another form of research. It should meet a local need.

When complete, the project closes with a presentation to the other course members, faculty, and often their managers, commissioners or other people of influence in their area. The group chooses a winner and runner up who receive an award at an evening event.


Spotlight projects


Identifying polypharmacy risk and improving medication optimisation in MS patients
By Dr Deepthi Vinayan Changaradil, consultant neurologist, Lewisham & Greenwich NHS Foundation Trust
Innovating Men's Health in MS: A Dedicated Clinic Model
By Maria Antoniou, MS clinical nurse specialist & Abraham Ignacio, clinical nurse specialist, University College London Hospitals NHS Foundation Trust
Service Audit Multiple Sclerosis Service Review: Impact of Employing a DMT Coordinator
By Shiny Basil, MS clinical nurse specialist, Basildon and Thurrock University Hospitals NHS Foundation Trust

All projects


Showing 1-9 of 68 projects

Identifying polypharmacy risk and improving medication optimisation in MS patients
By Dr Deepthi Vinayan Changaradil, consultant neurologist, Lewisham & Greenwich NHS Foundation Trust
Patient’s experience with subcutaneous Ocrelizumab at Lancashire Teaching Hospital NHS Foundation Trust
By Dr Suhaib Mohammed, neurology specialty registrar, Lancashire Teaching Hospitals NHS Foundation Trust
Intravenous vs Subcutaneous Natalizumab With Extended Interval Dosing: A Comparison
By Dr Pavlos Theodorou, neurology specialty registrar, University Hospitals Coventry and Warwickshire NHS Trust
Audit on use of Ponesimod in treatment of Relapsing Remitting Multiple Sclerosis in Teeside
By Dr Tanvi Shukla, stroke medicine locum consultan, North Tees and Hartlepool NHS Foundation Trust
DMT switch from natalizumab to ocrelizumab or fingolimod in relapsing remitting MS patients: a retrospective study to measure outcome
By Sanjida Chowdhury, Specialty registrar, Nottingham University Hospitals NHS Trust & Dr Shahjalal Khan, Neurology registrar, Nottingham University Hospitals NHS Trust
Natalizumab safety monitoring audit
By Zeinab Hamed, Speciality registrar, Sheffield teaching hospital
A Therapy led Sativex service – a retrospective audit of patient outcomes
By Jenny Thain, MS clinical specialist physiotherapist, The Walton Centre Liverpool
Siponimod use in Northern Ireland
By Conor Hughes, Clinical fellow, Royal Victoria Hospital
1 2 3